According to Benzinga Pro, during Q2, Limbach Holdings (NASDAQ:LMB) earned $1.35 million, a 6870.0% increase from the preceding quarter. Limbach Holdings also posted a total of $121.02 million in sales, a 6.77% increase since Q1.
According to Benzinga Pro, during Q2, Limbach Holdings (NASDAQ:LMB) earned $1.35 million, a 6870.0% increase from the preceding quarter. Limbach Holdings also posted a total of $121.02 million in sales, a 6.77% increase since Q1.
Gainers
PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering.